Wilson disease

Mayo Clinic Proceedings

Volumn 78, Issue 9, 2003, Pages 1126-1136

  El Youssef, Mounif ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; THIOMOLYBDIC ACID; TRIENTINE; ZINC;

CHELATION THERAPY; CHRONIC HEPATITIS; CLINICAL FEATURE; COPPER METABOLISM; CORNEA DISEASE; FEVER; GENOTYPE; HUMAN; LEUKOPENIA; LIVER FAILURE; LIVER TRANSPLANTATION; LYMPHADENOPATHY; PHENOTYPE; RASH; REVIEW; SIDEROBLASTIC ANEMIA; THROMBOCYTOPENIA; WILSON DISEASE;

EID: 0041356966     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.9.1126     Document Type: Review

References (62)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain. 1912; 34:295-509.
2. Loudianos G, Gitlin JD. Wilson's disease. Semin Liver Dis. 2000; 20:353-364.
3. Gitlin N. Wilson's disease: the scourge of copper. J Hepatol. 1998;28:734-739.
4. Kayser B. Ueber einen Fall fon angeborener grünlicher Verfärbung der Komea. Klin Monatsbl Augenheilkd. 1902;40:22-25.
5. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115:720-726.
6. Sternlieb I. Copper and the liver. Gastroenterology. 1980;78:1615-1628.
7. Bowcock AM, Farrer LA, Cavalli-Sforza LL, et al. Mapping the Wilson disease locus to a cluster of linked polymorphic markers on chromosome 13. Am J Hum Genet. 1987;41:27-35.
8. Adachi Y, Okuyama Y, Miya H, Kamisako T. Presence of ATP-dependent copper transport in the hepatocyte canalicular membrane of the Long-Evans cinnamon rat, an animal model of Wilson disease. J Hepatol. 1997;26:216-217.
9. Riordan SM, Williams R: The Wilson's disease gene and phenotypic diversity. J Hepatol. 2001;34:165-171.
10. Loudianos G, Dessi V, Lovicu M, et al. Mutation analysis in patients of Mediterranean descent with Wilson disease: identification of 19 novel mutations. J Med Genet. 1999;36:833-836.
11. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol. 1998;28(suppl 1):28-36.
12. Pfeil SA, Lynn DJ. Wilson's disease: copper unfettered. J Clin Gastroenterol. 1999;29:22-31.
13. Hung IH, Suzuki M, Yamaguchi Y, Yuan DS, Klausner RD, Gitlin JD. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem. 1997;272:21461-21466.
14. Payne AS, Kelly EJ, Gitlin JD. Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H 1069Q mutation. Proc Natl Acad Sci USA. 1998;95:10854-10859.
15. Schaefer M, Hopkins RG, Failla ML, Gitlin JD. Hepatocyte-specific localizafion and copper-dependent trafficking of the Wilson's disease protein in the liver. Am J Physiol. 1999;276(3, pt 1):G639-G646.
16. Hamza I, Faisst A, Prohaska J, Chen J, Gruss P, Gitlin JD. The metallochaperone Atoxl plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci U S A. 2001;98:6848-6852.
17. Gitlin JD, Aceruloplasminemia, Pediatr Res. 1998;44:271-276.
18. Cauza E, Maier-Dobersberger T, Polli C, Kaserer K, Kramer L, Ferenci P. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. J Hepatol. 1997;27:358-362.
19. Walshe JM, Diagnosis and treatment of presymptomatic Wilson's disease. Lancet. 1988;2:435-437.
20. Scott J, Gollan JL, Samourian S, Sherlock S. Wilson's disease. presenting as chronic active hepatitis. Gastroenterology. 1978;74: 645-651.
21. Wilson DC, Phillips MJ, Cox DW, Roberts EA. Severe hepatic Wilson's disease in preschool-aged children. J Pediatr. 2000;137: 719-722.
22. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut. 1986;27:1377-1381.
23. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology. 1991;100:762-767,
24. Ferlan-Marolt V, Stepec S. Fulminant Wilsonian hepatitis unmasked by disease progression: report of a case and review of the literature. Dig Dis Sci. 1999;44:1054-1058.
25. Yuce A, Kocak N, Gurakan F, Ozen H. Wilson's disease presented with fulminating hepatic failure in children [letter], Dig Dis Sci. 2000;45:704.
26. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987;146:261-265.
27. Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease. Hepatology. 1992;15:609-615.
28. Sallie R, Katsiyiannakis L, Baldwin D, et al. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology. 1992;16:1206-1211.
29. Kenngott S, Bilzer M. Inverse correlation of serum bilirubin and alkaline phosphatase in fulminant Wilson's disease. J Hepatol. 1998;29:683.
30. Sokol RJ, Twedt D, McKim JM Jr, et al, Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology. 1994;107:1788-1798.
31. Willeit J, Kiechl SG. Wilson's disease with neurological impairment but no Kayser-Fleischer rings [letter]. Lancet. 1991;337: 1426.
32. Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB. Diagnosis of Wilson's disease: an experience over three decades. Gut. 2000;46:415-419.
33. Topaloglu H, Gucuyener K, Orkun C, Renda Y. Tremor of tongue and dysarthria as the sole manifestation of Wilson's disease. Clin Neurol Neurosurg. 1990;92:295-296.
34. Walshe JM, Yealland M. Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry. 1992;55:692-696.
35. Giacchino R, Marazzi MG, Barabino A, et al. Syndromic variability of Wilson's disease in children: clinical study of 44 cases. Ital J Gastroenterol Hepatol. 1997;29:155-161.
36. Rosenfield N, Grand RJ, Watkins JB, Ballantine TV, Levey RH. Cholelithiasis and Wilson disease. J Pediatr. 1978;92:210-213.
37. Bearn AG, Yu TK, Gutman AB. Renal function in Wilson's disease. J Clin Invest. 1957;36:1107-1114.
38. Pyeritz RE. Genetic heterogeneity in Wilson disease: lessons from rare alleles [editorial]. Ann Intern Med. 1997;127:70-72.
39. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences [published correction appears in Nat Genet. 1995;9:451]. Nat Genet. 1995;9:210-217. Nat Genet. 1995;9:210-217.
40. Perman JA, Werlin SL, Grand RJ, Watkins JB. Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. J Pediatr. 1979;94:564-568.
41. Petrukhin K, Fischer SG, Pirastu M, et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet. 1993;5:338-343.
42. Houwen RH, Juyn J, Hoogenraad TU, Ploos van Amstel JK, Berger R. H714Q mutation in Wilson disease is associated with late, neurological presentation. J Med Genet. 1995;32:480-482.
43. Kemppainen R, Palatsi R, Kallioinen M, Oikarinen A. A homozygous nonsense mutation and a combination of two mutations of the Wilson disease gene in patients with different lysyl oxidase activities in cultured fibroblasts. J Invest Dermatol. 1997;108:35-39.
44. Maier-Dobersberger T, Ferenci P, Polli C, et al. Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med. 1997;127:21-26.
45. Gaffney D, Walker JL, O'Donnell JG, et al. DNA-based pre-symptomatic diagnosis of Wilson disease. J Inherit Metab Dis. 1992;15:161-170.
46. Chowrimootoo GF, Andoh J, Seymour CA. Western blot analysis in patients with hypocaemloplasminaemia. QJM. 1997;90:197-202.
47. Walshe JM. Treatment of Wilson's disease: the historical background. QJM. 1996;89:553-555.
48. Durand F, Bemuau J, Giostra E, et al. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut. 2001;48:849-852.
49. Walshe JM, Dixon AK. Dangers of non-compliance in Wilson's disease. Lancet. 1986;1:845-847.
50. Van Caillie-Bertrand M, Degenhart HJ, Luijendijk I, Bouquet J, Sinaasappel M. Wilson's disease: assessment of D-penicillamine treatment. Arch Dis Child. 1985;60:652-655.
51. Santos Silva EE, Sarles J, Buts JP, Sokal EM. Successful medical treatment of severely decompensated Wilson disease. J Pediatr. 1996;128:285-287.
52. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore). 1992;71:139-164.
53. Dubois RS, Rodgerson DO,Hambidge KM. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). J Pediatr Gastroenterol Nutr. 1990;10:77-81.
54. Dahlman T, Hartvig P, Lofholm M, Nordlinder H, Loof L, Westermark K. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine). QJM. 1995;88: 609-616.
55. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, Dick RD, Wang Y. Treatment of Wilson's disease with zinc XII: dose regimen requirements. Am J Med Sci. 1993;305:199-202.
56. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med. 1983;99:314-319.
57. Brewer GJ. Treatment of Wilson's disease with zinc [letter]. J Lab Clin Med. 1999;134:322-324.
58. Hoogenraad TU. Zinc treatment of Wilson's disease [editorial]. J Lab Clin Med. 1998;132:240-241.
59. Sternlieb I. Wilson's disease: indications for liver transplants. Hepatology. 1984;4(1, suppl):15S-17S.
60. Zitelli BJ, Malatack JJ, Gartner JC, et al. Orthotopic liver-transplantation in children with hepatic-based metabolic disease. Trans Proc. 1983;15:1284-1287.
61. Bellary S, Hassanein T, Van Thiel DH. Liver transplantation for Wilson's disease. J Hepatol. 1995;23:373-381.
62. Irani AN, Malhi H, Slehria S, et al. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease. Mol Ther. 2001; 3:302-309.